Research Library

A team of experts recommends community-based strategies for increasing vaccine acceptance in the USA as a means for controlling the COVID-19 pandemic.

Vaccines and other biomedical advances will not be sufficient to halt COVID-19, unless we simultaneously counter anti-science aggression, writes Peter Hotez, fellow in disease and poverty, in a new article for PLOS Biology.

Global deworming programs for children were once believed to improve a child’s chances for health, growth and success in school. New research that claims to debunk the merit of such programs has set off so-called “worm wars” between investigators. The authors aim to resolve the issue through an extended comparison of findings from key economics and epidemiological studies.

The authors discuss Pakistan’s challenges with neglected tropical diseases (NTDs) and their impact on poverty, child development and overall health in the country.

Treating intestinal worm infections leads to improved human development and childhood education, shows a study by Center for Health & Biosciences postdoctoral fellow SuJin Kang and fellows Peter Hotez and Farhan Majid.

Disease and poverty fellow Peter J. Hotez examines the rise of neglected tropical diseases (NTDs) in Texas, arguing that the spread of diseases like chikungunya West Nile, Zika and Ebola has not occurred by accident but instead reflects rapidly evolving changes and shifts in a “new” Texas beset by modern and globalizating forces.

The Global Burden of Disease Study is a landmark World Health Organization initiative that systematically quantifies the prevalence, morbidity, and mortality for hundreds of diseases, injuries, and risk factors of global health importance. In this article, the authors identify country-specific estimates of the prevalence or incidence of neglected tropical diseases, including cholera, typhoid and scabies.

This article, published by JAMA Pediatrics, examines how vaccine hesitancy may impact the number of annual measles cases in the U.S., finding that a 5 percent reduction in MMR vaccinations could cause a three-fold increase in measles cases and lead to a $2.1 million increase in public health costs.